| Modeling Ewing sarcoma tumors in vitro with 3D scaffolds ELS Fong, SE Lamhamedi-Cherradi, E Burdett, V Ramamoorthy, AJ Lazar, ... Proceedings of the National Academy of Sciences 110 (16), 6500-6505, 2013 | 272 | 2013 |
| Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma M Santoro, SE Lamhamedi-Cherradi, BA Menegaz, JA Ludwig, AG Mikos Proceedings of the National Academy of Sciences 112 (33), 10304-10309, 2015 | 114 | 2015 |
| Multimodality treatment of desmoplastic small round cell tumor: chemotherapy and complete cytoreductive surgery improve patient survival V Subbiah, SE Lamhamedi-Cherradi, B Cuglievan, BA Menegaz, ... Clinical Cancer Research 24 (19), 4865-4873, 2018 | 79 | 2018 |
| A spatially resolved single cell genomic atlas of the adult human breast T Kumar, K Nee, R Wei, S He, QH Nguyen, S Bai, K Blake, Y Gong, ... Nature 620, 181–191, 2023 | 64 | 2023 |
| Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer EH Lips, T Kumar, A Megalios, LL Visser, M Sheinman, A Fortunato, ... Nature genetics 54 (6), 850-860, 2022 | 61* | 2022 |
| 3D tissue-engineered model of Ewing's sarcoma SE Lamhamedi-Cherradi, M Santoro, V Ramammoorthy, BA Menegaz, ... Advanced drug delivery reviews 79, 155-171, 2014 | 58 | 2014 |
| IGF-1R and mTOR blockade: novel resistance mechanisms and synergistic drug combinations for Ewing sarcoma SE Lamhamedi-Cherradi, BA Menegaz, V Ramamoorthy, D Vishwamitra, ... JNCI: Journal of the National Cancer Institute 108 (12), djw182, 2016 | 56 | 2016 |
| An oral formulation of YK-4-279: preclinical efficacy and acquired resistance patterns in Ewing sarcoma SE Lamhamedi-Cherradi, BA Menegaz, V Ramamoorthy, RA Aiyer, ... Molecular cancer therapeutics 14 (7), 1591-1604, 2015 | 53 | 2015 |
| Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor BA Menegaz, B Cuglievan, J Benson, P Camacho, ... The oncologist, theoncologist. 2017-0408, 2017 | 47 | 2017 |
| Effects of shear stress gradients on ewing sarcoma cells using 3D printed scaffolds and flow perfusion JE Trachtenberg, M Santoro, C Williams III, CM Piard, BT Smith, ... ACS Biomaterials Science & Engineering 4 (2), 347-356, 2018 | 40 | 2018 |
| Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma ER Molina, LK Chim, MC Salazar, SM Mehta, BA Menegaz, ... Acta biomaterialia 100, 38-51, 2019 | 36 | 2019 |
| Preclinical Efficacy of Endoglin-Targeting Antibody–Drug Conjugates for the Treatment of Ewing Sarcoma P Puerto-Camacho, AT Amaral, SE Lamhamedi-Cherradi, BA Menegaz, ... Clinical Cancer Research, 2018 | 34 | 2018 |
| Modeling Stroma-Induced Drug Resistance In A Tissue-Engineered Tumor Model Of Ewing Sarcoma M Santoro, BA Menegaz, SE Lamhamedi-Cherradi, ER Molina, D Wu, ... Tissue Engineering, 2016 | 31 | 2016 |
| IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers HM Amin, AC Morani, NC Daw, SE Lamhamedi-Cherradi, V Subbiah, ... Cancers 12 (7), 1768, 2020 | 26 | 2020 |
| The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma SE Lamhamedi-Cherradi, M Maitituoheti, BA Menegaz, S Krishnan, ... Nature Communications 13 (1), 1-16, 2022 | 21 | 2022 |
| 3D Tissue-Engineered Tumor Model for Ewing’s Sarcoma That Incorporates Bone-like ECM and Mineralization ER Molina, LK Chim, MC Salazar, GL Koons, BA Menegaz, ... ACS Biomaterials Science & Engineering 6 (1), 539-552, 2019 | 20 | 2019 |
| Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma SE Lamhamedi-Cherradi, S Mohiuddin, DK Mishra, S Krishnan, ... Cancer gene therapy 28 (12), 1325-1338, 2021 | 18 | 2021 |
| Efficacy of ONC201 in Desmoplastic Small Round Cell Tumor AA Hayes-Jordan, X Ma, BA Menegaz, SE Lamhamedi-Cherradi, ... Neoplasia 20 (5), 524-532, 2018 | 12 | 2018 |
| Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study RSJM Schmitz, AW van den Belt-Dusebout, K Clements, Y Ren, C Cresta, ... bmj 383, 2023 | 11 | 2023 |
| Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk MM Almekinders, T Bismeijer, T Kumar, F Yang, B Thijssen, ... British journal of cancer 127 (7), 1201-1213, 2022 | 11 | 2022 |
Branko CuglievanPediatric Oncology, MD Anderson Cancer CenterVerified email at mdanderson.org
